Announced
Completed
Financials
Tags
Single Bidder
Cross Border
immunodiagnostics
Acquisition
United Kingdom
Friendly
Biotechnology
Majority
Public
Completed
Synopsis
PerkinElmer, a listed diagnostics solutions provider, completed the acquisition of Immunodiagnostic Systems, an in-vitro diagnostics company, for $155m. Through this acquisition, PerkinElmer will be able to grow its overall Diagnostics business and specifically its immunodiagnostics segment. Moreover, the deal will enable PerkinElmer to combine its channel expertise and testing capabilities with IDS’s best-in-class chemiluminescence products in endocrinology, autoimmunity and infectious diseases to better serve customers around the world.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.